Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Galecto Biotech patents

List of Galecto Biotech patents

List of The Raymond Corporation patents

List of Abengoa Solar patents

List of Inceptus Medical patents

List of companies in Frist Cressey Ventures's investment portfolio

Generative AI companies

Patents where

Current Assignee

Name

is

Galecto Biotech

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11377464 Galactoside inhibitor of galectins	Patent 11377464 was granted and assigned to Galecto Biotech on July, 2022 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	11377464	July 5, 2022
	‌ US Patent 10889610 Alpha-D-galactoside inhibitors of galectins	Patent 10889610 was granted and assigned to Galecto Biotech on January, 2021 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10889610	January 12, 2021
	‌ US Patent 9580456 Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis	Patent 9580456 was granted and assigned to Galecto Biotech on February, 2017 by the United States Patent and Trademark Office.		Galecto Biotech		United States Patent and Trademark Office	9580456	February 28, 2017
	‌ US Patent 10988502 Alpha-D-galactoside inhibitors of galectins	Patent 10988502 was granted and assigned to Galecto Biotech on April, 2021 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10988502	April 27, 2021
	‌ US Patent 11046725 Galactoside inhibitor of galectins	Patent 11046725 was granted and assigned to Galecto Biotech on June, 2021 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	11046725	June 29, 2021
	‌ US Patent 11406655 Once-daily treatment of pulmonary fibrosis		Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	11406655	August 9, 2022
	‌ US Patent 11447517 Galactoside inhibitor of galectins	Patent 11447517 was granted and assigned to Galecto Biotech on September, 2022 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	11447517	September 20, 2022
	‌ US Patent 9243021 Galactoside inhibitor of galectins	Patent 9243021 was granted and assigned to Galecto Biotech on January, 2016 by the United States Patent and Trademark Office.		Galecto Biotech		United States Patent and Trademark Office	9243021	January 26, 2016
	‌ US Patent 10464964 Galactoside inhibitor of galectins	Patent 10464964 was granted and assigned to Galecto Biotech on November, 2019 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10464964	November 5, 2019
	‌ US Patent 9688713 Galactoside inhibitor of galectins	Patent 9688713 was granted and assigned to Galecto Biotech on June, 2017 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	9688713	June 27, 2017
	‌ US Patent 9353141 Galectoside inhibitors of galectins	Patent 9353141 was granted and assigned to Galecto Biotech on May, 2016 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	9353141	May 31, 2016
	‌ US Patent 10253059 Hybrid galactoside inhibitor of galectins	Patent 10253059 was granted and assigned to Galecto Biotech on April, 2019 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10253059	April 9, 2019
	‌ US Patent 10774102 Galactoside inhibitor of galectins	Patent 10774102 was granted and assigned to Galecto Biotech on September, 2020 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10774102	September 15, 2020
	‌ US Patent 10307403 Polymorphic forms and process	Patent 10307403 was granted and assigned to Galecto Biotech on June, 2019 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10307403	June 4, 2019
	‌ US Patent 10369136 Polymorphic forms and process	Patent 10369136 was granted and assigned to Galecto Biotech on August, 2019 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10369136	August 6, 2019
	‌ US Patent 10730902 1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins		Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10730902	August 4, 2020
	‌ US Patent 10799482 Polymorphic forms and process		Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	10799482	October 13, 2020
	‌ US Patent 11939349 Galactoside inhibitor of galectins	Patent 11939349 was granted and assigned to Galecto Biotech on March, 2024 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	11939349	March 26, 2024
	‌ US Patent 11919921 Galactoside inhibitor of galectins	Patent 11919921 was granted and assigned to Galecto Biotech on March, 2024 by the United States Patent and Trademark Office.	Galecto Biotech	Galecto Biotech		United States Patent and Trademark Office	11919921	March 5, 2024

19 results

0 selected

19 results

0 selected